|
Post by mnkdfann on May 10, 2019 19:14:10 GMT -5
Nate... sparkrov I’ll be providing an update of my thoughts re: $MNKD in the May issue when it comes out next weekend... thanks for the interest!Classic pivot. How much time generally passes between what he writes to his subscribers in an update, until non-subscriber retail investors hear about it?
|
|
|
Post by mnkdfann on May 10, 2019 11:25:37 GMT -5
How many of the top execs usually show up at the ASM?
I wonder whether as many of them will be there, compared to years past.
|
|
|
Post by mnkdfann on May 10, 2019 9:38:57 GMT -5
Every limbo boy and girl All around the limbo world Gonna do the limbo rock All around the limbo clock Jack be limbo, Jack be quick Jack go unda limbo stick All around the limbo clock Hey, let's do the limbo rock Limbo lower now Limbo lower now How low can you go
|
|
|
Post by mnkdfann on May 10, 2019 8:17:17 GMT -5
Does anyone here think that there is a connection between the drop in price for both MNKD and UTHR? I can't speak for everyone or anyone else, but I would say there is no connection (other than overall market weakness hurting both). Also, UTHR recently reported a year over year decline in earnings (by about 5%).
|
|
|
Post by mnkdfann on May 9, 2019 12:03:51 GMT -5
Why would Deerfield prevent Mannkind from licensing Mannkind's own patents, in order to (as a byproduct) make money to repay Deerfield?
The SEC file I posted earlier also talks about patents held with others, e.g. UTHR.
|
|
|
Post by mnkdfann on May 9, 2019 10:08:47 GMT -5
My understanding is as follows once the DF debt is paid off: 3, The Mann Foundation is owed $90m in 2021 which is convertable at $4 per share. I will be happy to see this conveted at $4 per share personally. It is The Mann Group that has the option to convert. So conversion is not gteed. And certainly not at $4 (Mann can renegotiate, or else refuse to convert). "On March 11, 2018, the Company amended and restated the Mann Group Loan Arrangement to, among other things, (i) reflect the current outstanding principal balance of the existing loan of $71.5 million, after giving effect to the partial cancelation of principal in exchange for shares of the Company’s common stock described below; (ii) extend the maturity date of the loan to July 1, 2021; (iii) for periods beginning after April 1, 2018 require interest to compound quarterly; and (iv) permit the principal and any accrued and unpaid interest under the Mann Group Loan Arrangement to be converted, at the option of The Mann Group, at any time on or prior to close of business on the business day immediately preceding the stated maturity date, into shares of the Company’s common stock. The conversion rate of 250 shares per $1,000 principal amount of the Note, which is equal to $4.00 per share subject to adjustment under certain circumstances as described in the Mann Group Loan Arrangement."
|
|
|
Post by mnkdfann on May 9, 2019 9:09:36 GMT -5
The current SOC is a "Treat to Fail" protocol and as the "Father" of metformin approval in the U.S. - Dr. Ralph DeFronzo now says after he has learned the hard way “The most waste in type 2 diabetes is to continuously put people on metformin and sulfonylureas (glyburide, glimepiride, etc.). These drugs have no protective effect on the beta cell, and by the time you figure out what you’re doing, there are no beta cells left to save.” – Dr. Ralph DeFronzo (University of Texas Health Science Center) The SoC is a way to scale the treatment of diabetics, especially T2. It's driven by endos who base their decisions on a clear methodology with large scale trial data as the most influential. If there is no solid trial data to support a change it isn't going to happen. If you want to see the direction treatment is going look at the ADA - EASD joint statement as this drives future direction. Thank goodness Kendall said his task of changing the SOC to favour Afrezza is the easiest job he's ever had (or similar words to that effect).
|
|
|
Post by mnkdfann on May 9, 2019 8:42:59 GMT -5
Details regarding debt etc. are in 'Section 6. Related-Party Arrangements' and 'Section 7. Borrowings' of the 10-Q. Too complicated (IMO) to summarise the whole thing here. But it looks like some of the Mann Group debt was paid out / converted into stock, but not all of it. But there are also other borrowings to be paid out: seekingalpha.com/filing/4475644
|
|
|
Post by mnkdfann on May 9, 2019 8:25:40 GMT -5
"And your title is misleading." I didn't. There is a big "?" in the title. The figures were from the CC and they did not mention anything about Mann foundation. At least you know better now. Debt free is a long ways off.
|
|
|
Post by mnkdfann on May 8, 2019 15:57:57 GMT -5
What a hit of Afrezza would do to increase awareness. So which do you think it is, he did not use Afrezza in the presence of the reporter, or the reporter had no interest in talking about it? I'm not diabetic, so I may be way off, but given that this was Conor's meal (see below) wouldn't he need to take something? --- So what did Daly order? “I had the tofu… they do something with the tofu that was really good and then the jackfruit which was barbecued jackfruit with some rice and then they have some secret sauce which is really good,” he said.
|
|
|
Post by mnkdfann on May 7, 2019 22:09:33 GMT -5
Did you guys see what Adam said on Twitter today? This? "I tried to warn you about $MNKD. Everyone tried to warn you about $MNKD. Live and learn. Best — Adam"
|
|
|
Post by mnkdfann on May 7, 2019 21:18:46 GMT -5
i heard a lot of good things on this call but is it me or are we turning into stocktwits. oh well who cares i'm in for the long haul and i know who to pay attention to on this board. I won't say I heard a lot of good things on the call, but I actually thought the call wasn't that bad. And really not much better or worse than some recent previous ones. Mind you, I sold my relatively few remaining MNKD shares some months ago in the $1.80 range. Given how the overall markets behaved today, I thought MNKD stock held up reasonably well all things considered.
|
|
|
Post by mnkdfann on May 7, 2019 16:30:00 GMT -5
As a Canuck, I also like where Mike described Canada as being 'kind'. Love you too, Mike.
(If 'kind' was a typo in the transcript, I don't want to hear about it.)
|
|
|
Post by mnkdfann on May 7, 2019 16:22:43 GMT -5
Good read. I 'like' where Mike said: "[W]e do have high market share in people that have been using the drug" Does that line make sense to anyone? Isn't it like saying, say, among those people who like pizza, a large percentage of them like pizza?
|
|
|
Post by mnkdfann on May 7, 2019 14:23:58 GMT -5
MNKD certainly had bad luck picking a day for an earnings call, didn't it?
|
|